Flavonoids as inhibitors of human neutrophil elastase

81Citations
Citations of this article
167Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Elastase is a proteolytic enzyme belonging to the family of hydrolases produced by human neutrophils, monocytes, macrophages, and endothelial cells. Human neutrophil elastase is known to play multiple roles in the human body, but an increase in its activity may cause a variety of diseases. Elastase inhibitors may prevent the development of psoriasis, chronic kidney disease, respiratory disorders (including COVID-19), immune disorders, and even cancers. Among polyphenolic compounds, some flavonoids and their derivatives, which are mostly found in herbal plants, have been revealed to influence elastase release and its action on human cells. This review focuses on elastase inhibitors that have been discovered from natural sources and are biochemically characterised as flavonoids. The inhibitory activity on elastase is a characteristic of flavonoid aglycones and their glycoside and methylated, acetylated and hydroxylated derivatives. The presented analysis of structure–activity relationship (SAR) enables the determination of the chemical groups responsible for evoking an inhibitory effect on elastase. Further study especially of the in vivo efficacy and safety of the described natural compounds is of interest in order to gain better understanding of their health-promoting potential.

Cite

CITATION STYLE

APA

Jakimiuk, K., Gesek, J., Atanasov, A. G., & Tomczyk, M. (2021). Flavonoids as inhibitors of human neutrophil elastase. Journal of Enzyme Inhibition and Medicinal Chemistry. Taylor and Francis Ltd. https://doi.org/10.1080/14756366.2021.1927006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free